Revolution Medicines's Total Assets for the quarter that ended in Sep. 2024 was $1,763.00 Mil.
During the past 12 months, Revolution Medicines's average Total Assets Growth Rate was 24.80% per year.
During the past 3 years, the average Total Assets Growth Rate was 18.10% per year.
During the past 5 years, the average Total Assets Growth Rate was 16.90% per year.
During the past 7 years, Revolution Medicines's highest 3-Year average Total Assets Growth Rate was 176.40%. The lowest was 16.80%. And the median was 18.80%.
The historical data trend for Revolution Medicines's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Revolution Medicines's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revolution Medicines (NAS:RVMD) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Sep. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Revolution Medicines's Asset Turnover for the quarter that ended in Sep. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Revolution Medicines Total Assets Related Terms
Thank you for viewing the detailed overview of Revolution Medicines's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RVMD has been successfully added to your 